[Treatment of acute and chronic coronary insufficiency with carbochromen].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D000925:Anticoagulants / Q000627:therapeutic use*; D002908:Chronic Disease; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007022:Hypotension / Q000139:chemically induced; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D010146:Pain / Q000139:chemically induced; D012893:Sleep Wake Disorders / Q000139:chemically induced; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014717:Vertigo / Q000139:chemically induced
D000925:Anticoagulants; D014665:Vasodilator Agents
Die Behandlung der akuten und chronischen Coronarinsuffizienz mit Carbochromen.